Psychoneuroendocrinology
Volume 35, Issue 2 , Pages 226-232 , February 2010

Serum chemokine levels in major depressive disorder

  • Soili M. Lehto

      Affiliations

    • Department of Psychiatry, Kuopio University Hospital and University of Kuopio, 70210 Kuopio, Finland
    • Kuopio Psychiatric Center, P.O. Box 1777, 70211 Kuopio, Finland
    • Corresponding Author InformationCorresponding author at: Department of Psychiatry, Kuopio University Hospital and University of Kuopio, 70210 Kuopio, Finland. Tel.: +358 40 8277 973; fax: +358 17 17 2966.
    • ,
  • Leo Niskanen

      Affiliations

    • Department of Medicine, Kuopio University Hospital and University of Kuopio, 70210 Kuopio, Finland
    • ,
  • Karl-Heinz Herzig

      Affiliations

    • Department of Psychiatry, Kuopio University Hospital and University of Kuopio, 70210 Kuopio, Finland
    • Institute of Biomedicine, Division of Physiology and Biocenter Oulu, University of Oulu, Finland
    • ,
  • Tommi Tolmunen

      Affiliations

    • Department of Psychiatry, Kuopio University Hospital and University of Kuopio, 70210 Kuopio, Finland
    • ,
  • Anne Huotari

      Affiliations

    • Institute of Biomedicine, Division of Physiology and Biocenter Oulu, University of Oulu, Finland
    • ,
  • Heimo Viinamäki

      Affiliations

    • Department of Psychiatry, Kuopio University Hospital and University of Kuopio, 70210 Kuopio, Finland
    • ,
  • Heli Koivumaa-Honkanen

      Affiliations

    • Department of Psychiatry, Kuopio University Hospital and University of Kuopio, 70210 Kuopio, Finland
    • Department of Clinical Medicine, University of Oulu, 90014 Oulu, Finland
    • Department of Psychiatry, Lapland Hospital District, 97140 Rovaniemi, Finland
    • ,
  • Kirsi Honkalampi

      Affiliations

    • Kuopio Psychiatric Center, P.O. Box 1777, 70211 Kuopio, Finland
    • ,
  • Heli Ruotsalainen

      Affiliations

    • Institute of Biomedicine, Division of Physiology and Biocenter Oulu, University of Oulu, Finland
    • ,
  • Jukka Hintikka

      Affiliations

    • Department of Psychiatry, Kuopio University Hospital and University of Kuopio, 70210 Kuopio, Finland

Received 17 February 2009 ,Revised 13 June 2009 ,Accepted 15 June 2009.

References 

  1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 4th edn. Washington, DC: DSM-IV; 1994;
  2. Babyak MA. What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosom. Med. 2004;66:411–421
  3. Baggiolini M. Chemokines and leukocyte traffic. Nature. 1998;392:565–568
  4. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry. 1961;4:561–571
  5. Cyranowski JM, Marsland AL, Bromberger JT, Whiteside TL, Chang Y, Matthews KA. Depressive symptoms and production of proinflammatory cytokines by peripheral blood mononuclear cells stimulated in vitro. Brain Behav. Immun. 2007;21:229–237
  6. de Haas AH, van Weering HR, de Jong EK, Boddeke HW, Biber KP. Neuronal chemokines: versatile messengers in central nervous system cell interaction. Mol. Neurobiol. 2007;36:137–151
  7. de Jager W, te Velthuis H, Prakken BJ, Kuis W, Rijkers GT. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin. Diagn. Lab. Immunol. 2003;10:133–139
  8. Elshal MF, McCoy JP. Multiplex bead array assays: performance evaluation and comparison of sensitivity to ELISA. Methods. 2006;38:317–323
  9. Guyon, A., Skrzydelski, D., De Giry, I., Rovère, C., Conductier, G., Trocello, J.M., Daugé, V., Kitabgi, P., Rostène, W., Nahon, J.L., Parsadaniantz, S.M., in press. Long term exposure to the chemokine CCL2 activates the nigrostriatal dopamine system: a novel mechanism for the control of dopamine release. Neuroscience, doi:10.1016/j.neuroscience.2009.05.048.
  10. Joukamaa M, Miettunen J, Kokkonen P, Koskinen M, Julkunen J, Kauhanen J, et al. Psychometric properties of the Finnish 20-item Toronto Alexithymia Scale. Nord. J. Psychiatry. 2001;55:123–127
  11. Kahl KG, Rudolf S, Stoeckelhuber BM, Dibbelt L, Gehl HB, Markhof K, et al. Bone mineral density, markers of bone turnover, and cytokines in young women with borderline personality disorder with and without comorbid major depressive disorder. Am. J. Psychiatry. 2005;162:168–174
  12. Khan IH, Krishnan VV, Ziman M, Janatpour K, Wun T, Luciw PA, et al. A comparison of multiplex suspension array large-panel kits for profiling cytokines and chemokines in rheumatoid arthritis patients. Cytometry B: Clin. Cytom. 2008;76B:159–168
  13. Khan SS, Smith MS, Reda D, Suffredini AF, McCoy JP. Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufacturers. Cytometry B: Clin. Cytom. 2004;61:35–39
  14. Koivumaa-Honkanen HT, Honkanen R, Viinamäki H, Heikkilä K, Kaprio J, Koskenvuo M. Self-reported life satisfaction and 20-year mortality in healthy Finnish adults. Am. J. Epidemiol. 2000;152:983–991
  15. Kronfol Z, Remick DG. Cytokines and the brain: implications for clinical psychiatry. Am. J. Psychiatry. 2000;157:683–694
  16. Leng SX, McElhaney JE, Walston JD, Xie D, Fedarko NS, Kuchel GA. ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. J. Gerontol. A: Biol. Sci. Med. Sci. 2008;63:879–884
  17. Li M, Ransohoff RM. Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology. Prog. Neurobiol. 2008;84:116–131
  18. Madrigal JL, Leza JC, Polak P, Kalinin S, Feinstein DL. Astrocyte-derived MCP-1 mediates neuroprotective effects of noradrenaline. J. Neurosci. 2009;29:263–267
  19. Maes M, Meltzer HY, Bosmans E, Bergmans R, Vandoolaeghe E, Ranjan R, et al. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J. Affect. Disord. 1995;34:301–309
  20. Merikangas KR, Zhang H, Avenevoli S, Acharyya S, Neuenschwander M, Angst J Zurich Cohort Study. Longitudinal trajectories of depression and anxiety in a prospective community study: the Zurich Cohort Study. Arch. Gen. Psychiatry. 2003;60:993–1000
  21. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry. 2009;65:732–741
  22. Podlipny, J., Hess, Z., Vrzalova, J., Rosolova, H., Beran, J., Petrlova, B., in press. Lower serum levels of interleukin-6 in a population sample with symptoms of depression than in a population sample without symptoms of depression. Physiol. Res.
  23. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006;27:24–31
  24. Rollins BJ. Chemokines. Blood. 1997;90:909–928
  25. Rothenbacher D, Müller-Scholze S, Herder C, Koenig W, Kolb H. Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers. Arterioscler. Thromb. Vasc. Biol. 2006;26:194–199
  26. Schiepers OJ, Wichers MC, Maes M. Cytokines and major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2005;29:201–217
  27. Simon NM, McNamara K, Chow CW, Maser RS, Papakostas GI, Pollack MH, et al. A detailed examination of cytokine abnormalities in major depressive disorder. Eur. Neuropsychopharmacol. 2008;18:230–233
  28. Skrzydelski D, Guyon A, Daugé V, Rovère C, Apartis E, Kitabgi P, et al. The chemokine stromal cell-derived factor-1/CXCL12 activates the nigrostriatal dopamine system. J. Neurochem. 2007;102:1175–1183
  29. Stewart, J.C., Rand, K.L., Muldoon, M.F., Kamarck, T.W., in press. A prospective evaluation of the directionality of the depression–inflammation relationship. Brain Behav. Immun., doi:10.1016/j.bbi.2009.04.011.
  30. Suarez EC, Krishnan RR, Lewis JG. The relation of severity of depressive symptoms to monocyte-associated proinflammatory cytokines and chemokines in apparently healthy men. Psychosom. Med. 2003;65:362–368
  31. Suarez EC, Lewis JG, Krishnan RR, Young KH. Enhanced expression of cytokines and chemokines by blood monocytes to in vitro lipopolysaccharide stimulation are associated with hostility and severity of depressive symptoms in healthy women. Psychoneuroendocrinology. 2004;29:1119–1128
  32. Sutcigil L, Oktenli C, Musabak U, Bozkurt A, Cansever A, Uzun O, et al. Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy. Clin. Dev. Immunol. 2007;76396
  33. Viinamäki H, Heiskanen T, Lehto SM, Niskanen L, Koivumaa-Honkanen H, Tolmunen T, et al. Depressive symptoms are associated with metabolic syndrome in men. Acta Psychiatr. Scand. 2009;120:23–29
  34. Whooley MA, Caska CM, Hendrickson BE, Rourke MA, Ho J, Ali S. Depression and inflammation in patients with coronary heart disease: findings from the Heart and Soul Study. Biol. Psychiatry. 2007;62:314–320
  35. Williams JBW, Terman M. Structured interview guide for the Hamilton Depression Rating Scale with Atypical Depression Supplement (SIGH-ADS). New York: New York State Psychiatric Institute; 2003;

PII: S0306-4530(09)00200-5

doi: 10.1016/j.psyneuen.2009.06.007

Psychoneuroendocrinology
Volume 35, Issue 2 , Pages 226-232 , February 2010

Article Tools